SCHEMBL4375909

SCHEMBL4375909

Nc1c(Cl)cnc(Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.32
PIK3CD O00329 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
PLAU P00749 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
GAA P10253 1/20 0.31
PDXK O00764 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL28550780 0.85
Formic Acid SCHEMBL28417459 0.85 TDP1 (0.32) TDP1
Formic Acid SCHEMBL28550777 0.85 TDP1 (0.32) TDP1
SCHEMBL6305842 0.81 HTT (0.40) DYRK1APIK3CDALDH1A1CYP3A4GAA
SCHEMBL7361765 0.79 DYRK1A (0.41) DYRK1AALDH1A1CYP3A4PLAUGAA
SCHEMBL7841635 0.79 HTT (0.34) DYRK1APIK3CDALDH1A1CYP3A4PLAU
SCHEMBL11610661 0.75 PLAU (0.33) DYRK1APLAU
SCHEMBL22207395 0.75 NOS3 (0.39) PIK3CDALDH1A1GAA
SCHEMBL22208146 0.75 CHEK1 (0.31) PIK3CD
SCHEMBL31413296 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119569700-A 6-Nitrogen-containing cyclopicolinic acid and partial formate compound thereof, and preparation method and application thereof 中国农业大学 2025-03-07 CN disclosed
CN-118217896-A Continuous reaction device and method for continuously preparing 4-amino-3, 5, 6-trichloropyridine nitrile 北京颖泰嘉和生物科技股份有限公司 2024-06-21 CN disclosed
US-20240099297-A1 HIGHLY LOADED EMULSIFIABLE CONCENTRATE FORMULATION OF TRICLOPYR AND PICLORAM Adama Australia Pty Limited (AU) 2024-03-28 US disclosed
US-20220371997-A1 PREPARATION OF HALOGEN ANALOGS OF PICLORAM CORTEVA AGRISCIENCE LLC (US) 2022-11-24 US disclosed
US-11401242-B2 Preparation of halogen analogs of picloram CORTEVA AGRISCIENCE LLC (US) 2022-08-02 US disclosed
US-20210323923-A1 PREPARATION OF HALOGEN ANALOGS OF PICLORAM CORTEVA AGRISCIENCE LLC (US) 2021-10-21 US disclosed
WO-2020061146-A1 PREPARATION OF HALOGEN ANALOGS OF PICLORAM DOW AGROSCIENCES LLC (US) 2020-03-26 WO disclosed
CN-110438522-A A kind of method that the dechlorination of electrochemistry selectivity prepares 4- amino -3,6- lontrel UNIV ZHEJIANG TECHNOLOGY 2019-11-12 CN disclosed
CN-105803481-B A kind of method that catalytic electrolysis prepares the formic acid of 4 amino, 3,6 dichloropyridine 2 浙江埃森化学有限公司 2018-03-27 CN disclosed
CN-104988531-B The method that a kind of selective dechlorination of chloro-pyridine formic acid electro-catalysis prepares pyridine carboxylic acid 浙江工业大学 2017-11-07 CN disclosed
US-7625919-B2 4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-12-01 US disclosed
US-7625919-B2 4-azasteroid derivatives as androgen receptor modulators MERCK & CO., INC. (US) 2009-12-01 US disclosed
US-20090291950-A1 BICYCLIC HETEROARYL INHIBITORS OF PDE4 KALYPSYS, INC. (US) 2009-11-26 US disclosed
WO-2008006052-A2 BICYCLIC HETEROARYL INHIBITORS OF PDE4 GOVEK STEVEN P (US) 2008-01-10 WO disclosed
US-20070072096-A1 Negative curable dye-containing composition, color filter, and method of manufacturing the same FUJI PHOTO FILM CO., LTD. 2007-03-29 US disclosed
CN-1219171-A Benzofuran carboxamides and their therapeutic use DARWIN DISCOVERY CO LTD (GB) 1999-06-09 CN disclosed
US-4066438-A HERBICIDES THE DOW CHEMICAL COMPANY (US) 1978-01-03 US disclosed
US-3883541-A 4-Amino-3,5,6-trichloro-2-(functionally substituted methyl) pyridine compounds DOW CHEMICAL CO 1975-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11401242-B2 Preparation of halogen analogs of picloram PBRM1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PHF6 DYRK1A 3992/4885PIK3CD 791/4885ALDH1A1 1275/4885
US-20090291950-A1 BICYCLIC HETEROARYL INHIBITORS OF PDE4 PDE4A, PDE4B, PDE4C DYRK1A 3055/4885PIK3CD 1504/4885ALDH1A1 552/4885
US-20210323923-A1 PREPARATION OF HALOGEN ANALOGS OF PICLORAM PBRM1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PHF6 DYRK1A 3992/4885PIK3CD 791/4885ALDH1A1 1275/4885
US-20220371997-A1 PREPARATION OF HALOGEN ANALOGS OF PICLORAM PBRM1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PHF6 DYRK1A 3992/4885PIK3CD 791/4885ALDH1A1 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.